Immune Pharmaceuticals INC
SEC CIK 1208261 · IMNPQ · last insider filing 2020-02-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Fiorino Anthony S. | Director · Chief Medical Officer and COO | filed 2017 - 2020 |
| Maza Elliot M | Director · Interim CEO | filed 2015 - 2017 |
| Kimball Ranch C | Director | filed 2017 - 2017 |
| Durrant Cameron | Director | filed 2014 - 2017 |
| Kazado Daniel | Director | filed 2013 - 2017 |
| Paley Jeffrey | Director | filed 2016 - 2017 |
| Neczesny John A. | Director | filed 2016 - 2017 |
| Teper Daniel Gedeon | Director · Chairman & CEO | filed 2013 - 2016 |
| Azria Rene Pierre | Director | filed 2015 - 2015 |
| Berdugo Gad | Director · EVP & CFO | filed 2014 - 2015 |
| Lerer Rene | Director | filed 2013 - 2015 |
| Sidransky David | Director | filed 2013 - 2015 |
| Stancic Ana | Director | filed 2013 - 2015 |
| Kobrin Isaac | Director | filed 2013 - 2014 |
| Cook Robert W. | Director · Interim Chief Exec. Officer | filed 2006 - 2014 |
| Albouy Pierre | Director | filed 2013 - 2013 |
| De Kergrohen Herve | Director | filed 2013 - 2013 |
| Savage Robert G. | Director | filed 2006 - 2013 |
| Dunton Alan W | Director | filed 2012 - 2013 |
| Brownlie Keith L | Director | filed 2011 - 2013 |
| Yetter Wayne P. | Director | filed 2006 - 2012 |
| Waldheim Gerhard | Director | filed 2006 - 2012 |
| Smyth A. Collier | Director | filed 2009 - 2012 |
| Talley John V. | Director · President, CEO and Director | filed 2006 - 2011 |
| Jackson Guy C. | Director | filed 2006 - 2010 |
| Caspritz Gert | Director | filed 2006 - 2008 |
| Bedard John F. | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Clark John P | See Remarks | filed 2018 - 2018 |
| Luchi Monica E. | See Remarks | filed 2015 - 2016 |
| Militello John | See Remarks | filed 2016 - 2016 |
| Ben-Ami Miri | See Remarks* | filed 2016 - 2016 |
| Allard Stephane | Chief Medical Officer | filed 2007 - 2012 |
| Bhagwat Dileep | Snr VP, Pharmaceutical Dvlpmt | filed 2006 - 2011 |
| Wiedemann Oliver | see remarks | filed 2006 - 2011 |
| Tyrrell Bernard R | Senior VP Sales & Marketing | filed 2009 - 2010 |
| Chen Michael | VP-Global Business Development | filed 2006 - 2009 |
| Tseng Ben | Chief Scientific Officer | filed 2006 - 2009 |
| Damask Michael C | Chief Medical Officer | filed 2006 - 2006 |
| Mcclurg Michael | VP- Business Dvpmt- Oncology | filed 2006 - 2006 |
| Lockhart Earle | VP Clinical & Rglatory Affairs | filed 2006 - 2006 |
| Elefant Dov | Controller- VP Finance & Admin | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.